Additional Titles & Roles
- Director, Child and Adolescent Psychiatry Residency Research Education Program (CAP-PRREP)
- Director, Digital and Health Integrative Research, Employee and Family Mental Health & Wellness Center
- Director, Mobile Health Research Core (MHRC)
- Co-Director, Healthy Mind Lab
Education & Training
- Postdoctoral Training: Biomedical Research Training in Drug Abuse, 2010
- Fellowship: Washington University, St. Louis, MO, 2007
- Residency: Washington University, St. Louis, MO, 2005
- M.D.: University of Iowa, 2002
- B.A.: University of Iowa, 1998
Major Awards
- Child Fellowship Mentoring Award, Washington University School of Medicine, Department of Psychiatry, 2019
- Resident Mentoring Award, Washington University School of Medicine, Department of Psychiatry, 2018
- Mortimer Goodman Award for Outstanding Contribution to Mental Health through MO NAMI, 2014
- Eli Robins Award for Excellence in Clinical Psychiatry, Teaching and Research, 2007
Areas of Clinical Interest
Obesity and metabolic health in children, adults and older adults with severe mental illness; eating disorders; medical weight management.
Research Interests
Identification and prevention of cardiometabolic risk in mentally ill populations, psychopharmacology, medical and behavioral treatment of obesity and eating disorders in children, adults and older adults.
Recent Publications
-
Correction to: Psilocybin’s acute and persistent brain effects: a precision imaging drug trial (Scientific Data, (2025), 12, 1, (941), 10.1038/s41597-025-05189-0)
Subramanian, S., Reneau, T. R., Perry, D., Chacko, R., Laumann, T. O., Flavin, K., Horan, C., Schweiger, J., Metcalf, N., Lenze, E. J., Snyder, A., Dosenbach, N. U. F., Nicol, G. & Siegel, J., Dec 2025, In: Scientific data. 12, 1, 1029.
-
Psilocybin’s acute and persistent brain effects: a precision imaging drug trial
Subramanian, S., Renau, T. R., Perry, D., Chacko, R., Laumann, T. O., Flavin, K., Horan, C., Schweiger, J., Metcalf, N., Lenze, E. J., Snyder, A. Z., Dosenbach, N. U. F., Nicol, G. & Siegel, J. S., Dec 2025, In: Scientific data. 12, 1, 941.
-
High-Frequency, At-Home Monitoring of Drug Safety and Tolerability in Clinical Trials: Results From Studies of Fluvoxamine for COVID-19 Treatment
Lenze, E. J., Nykamp, M., Miller, J. P., Stevens, A., Schweiger, J., Gettinger, T., Yingling, M., Zhang, Y., Nicol, G. E., Zorumski, C. F. & Reiersen, A. M., Jul 2025, In: Clinical and translational science. 18, 7, e70292.
-
Shrinking the know–do gap in psychedelic-assisted therapy
Nicol, G. E., Adams, D. R., Lenze, E. J. & Cabassa, L. J., Apr 2025, In: Nature Human Behaviour. 9, 4, p. 665-672 8 p., 109610.
-
Protocol for a pilot clinical trial of the senolytic drug combination Dasatinib Plus Quercetin to mitigate age-related health and cognitive decline in mental disorders
Schweiger, A., Diniz, B., Nicol, G., Schweiger, J., Dasklakis-Perez, A. E. & Lenze, E. J., 2025, In: F1000Research. 13, 1072.